14729-D9831C00002- 1 Month Biopsy Study

• Status: Completed
• Trial end date: 2009-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to study histological changes, cellularity, clinical efficacy and safety of AZD1981 in patients with Chronic Obstructive Pulmonary Disease

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca

Criteria

Inclusion Criteria:

• Men or women 40 years or above

• FEV1 between 40 and 80% of predicted normal value post-bronchodilator

• Clinical diagnosis of COPD

Exclusion Criteria:

• Other clinically relevant disease or disorders

• Exacerbation of COPD within 30 days